Ascendis Pharma A/S EV - Enterprise Value 2011-2026 | ASND

Annual EV - Enterprise Value Ascendis Pharma A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
849 M	726 M	579 M	382 M	7.12 B	8 B	5.95 B	2.34 B	1.18 B	394 M	344 M	349 M	20.4 M	23.8 M	22.6 M

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
8 B	20.4 M	1.88 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
Black Diamond Therapeutics BDTX	107 M	$ 2.38	-3.64 %	$ 131 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Alector ALEC	444 M	$ 2.1	-13.79 %	$ 216 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	-18.3 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	442 M	$ 4.2	-2.67 %	$ 298 M	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	22.6 M	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	86.9 M	-	-	$ 521 M	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Apellis Pharmaceuticals APLS	3.01 B	$ 20.61	-1.67 %	$ 2.6 B	USA
Agenus AGEN	-75.9 M	$ 3.33	-	$ 1.19 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	1.65 B	$ 28.87	-4.5 %	$ 1.67 B	USA
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA